Literature DB >> 11427256

Assembly of synthetic peptide vaccines by chemoselective ligation of epitopes: influence of different chemical linkages and epitope orientations on biological activity.

W Zeng1, S Ghosh, M Macris, J Pagnon, D C Jackson.   

Abstract

In this paper, we describe the assembly of synthetic peptide vaccines composed of a T helper cell epitope and a B cell epitope that were synthesized separately and then attached using three different chemoselective ligation methods: oxime bond formation, thioether bond formation and disulfide bond formation. The resulting vaccines were tested in animals to investigate their efficacy. We found that thioether bond formation gave the highest yield of material and that the chemistry involved did not adversely affect immunogenicity and biological activity of the peptide vaccine. Ligation of epitopes by oxime bond formation did not diminish biological activity either, but the yields of peptide vaccine were lower than when thioether bond formation was used. The vaccines in which a disulfide bond was used to attach the two epitopes resulted in the lowest yield and produced vaccines that also generated a weaker immune response with sub-optimal biological activity. Connecting the T helper epitope via its N-terminus or its C-terminus to the N-terminus of the B cell epitope had little influence on resulting immunogenicity and biological activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11427256     DOI: 10.1016/s0264-410x(01)00152-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  A modular approach to assembly of totally synthetic self-adjuvanting lipopeptide-based vaccines allows conformational epitope building.

Authors:  Weiguang Zeng; Kylie J Horrocks; Gorjana Robevska; Chinn Yi Wong; Kristy Azzopardi; Marija Tauschek; Roy M Robins-Browne; David C Jackson
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

Review 2.  Advances in the design and delivery of peptide subunit vaccines with a focus on toll-like receptor agonists.

Authors:  Matthew Black; Amanda Trent; Matthew Tirrell; Colleen Olive
Journal:  Expert Rev Vaccines       Date:  2010-02       Impact factor: 5.217

3.  Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles.

Authors:  Yoshio Fujita; Hiroaki Taguchi
Journal:  Chem Cent J       Date:  2011-08-23       Impact factor: 4.215

4.  Total chemical synthesis of a thermostable enzyme capable of polymerase chain reaction.

Authors:  Weiliang Xu; Wenjun Jiang; Jiaxing Wang; Linping Yu; Ji Chen; Xianyu Liu; Lei Liu; Ting F Zhu
Journal:  Cell Discov       Date:  2017-02-28       Impact factor: 10.849

5.  Double conjugation strategy to incorporate lipid adjuvants into multiantigenic vaccines.

Authors:  Waleed M Hussein; Tzu-Yu Liu; Pirashanthini Maruthayanar; Saori Mukaida; Peter M Moyle; James W Wells; Istvan Toth; Mariusz Skwarczynski
Journal:  Chem Sci       Date:  2016-01-04       Impact factor: 9.825

Review 6.  Peptide Lipidation - A Synthetic Strategy to Afford Peptide Based Therapeutics.

Authors:  Renata Kowalczyk; Paul W R Harris; Geoffrey M Williams; Sung-Hyun Yang; Margaret A Brimble
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.